Indie Asset Partners, LLC Eli Lilly & CO Transaction History

Indie Asset Partners, LLC

$129 Million
Q3 2024

A detailed history of Indie Asset Partners, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Indie Asset Partners, LLC holds 60,705 shares of LLY stock, worth $47.9 Million. This represents 41.74% of its overall portfolio holdings.

Number of Shares

60,705

Previous 60,698 0.01%

Holding current value

$47.9 Million

Previous $55 Million 2.14%

% of portfolio

41.74%

Previous 45.17%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	BUY	$772.14 - $960.02 $5,404 - $6,720	7 Added 0.01%	60,705 $53.8 Million
Q2 2024 Aug 05, 2024	SELL	$724.87 - $909.04 $3.1 Million - $3.89 Million	-4,282 Reduced 6.59%	60,698 $55 Million
Q1 2024 May 10, 2024	SELL	$592.2 - $792.28 $87,053 - $116,465	-147 Reduced 0.23%	64,980 $50.6 Million
Q4 2023 Jan 26, 2024	BUY	$525.19 - $619.13 $40,439 - $47,673	77 Added 0.12%	65,127 $38 Million
Q3 2023 Oct 27, 2023	BUY	$434.7 - $599.3 $26,516 - $36,557	61 Added 0.09%	65,050 $34.9 Million
Q2 2023 Aug 07, 2023	SELL	$350.74 - $468.98 $140,296 - $187,592	-400 Reduced 0.61%	64,989 $30.5 Million
Q1 2023 May 11, 2023	BUY	$310.63 - $364.82 $264,346 - $310,461	851 Added 1.32%	65,389 $22.5 Million
Q4 2022 Feb 01, 2023	SELL	$321.55 - $374.67 $712,554 - $830,268	-2,216 Reduced 3.32%	64,538 $23.6 Million
Q3 2022 Oct 25, 2022	SELL	$296.48 - $337.87 $26,683 - $30,408	-90 Reduced 0.13%	66,754 $21.6 Million
Q2 2022 Aug 12, 2022	SELL	$278.73 - $327.27 $9,755 - $11,454	-35 Reduced 0.05%	66,844 $21.7 Million
Q1 2022 May 10, 2022	SELL	$234.69 - $291.66 $42,244 - $52,498	-180 Reduced 0.27%	66,879 $19.2 Million
Q4 2021 Feb 11, 2022	SELL	$224.85 - $279.04 $134,910 - $167,424	-600 Reduced 0.89%	67,059 $18.5 Million
Q3 2021 Nov 09, 2021	SELL	$221.6 - $272.71 $11,080 - $13,635	-50 Reduced 0.07%	67,659 $15.6 Million
Q2 2021 Aug 11, 2021	SELL	$180.55 - $233.54 $48,748 - $63,055	-270 Reduced 0.4%	67,709 $15.5 Million
Q1 2021 May 13, 2021	SELL	$164.32 - $212.72 $173,193 - $224,206	-1,054 Reduced 1.53%	67,979 $12.7 Million
Q4 2020 Feb 09, 2021	BUY	$130.46 - $172.63 $44,356 - $58,694	340 Added 0.49%	69,033 $11.7 Million
Q3 2020 Nov 13, 2020	BUY	$146.22 - $169.13 $25,588 - $29,597	175 Added 0.26%	68,693 $10.2 Million
Q2 2020 Aug 12, 2020	BUY	$136.42 - $164.18 $105,043 - $126,418	770 Added 1.14%	68,518 $10.5 Million
Q1 2020 May 13, 2020	BUY	$119.05 - $147.35 $8,928 - $11,051	75 Added 0.11%	67,748 $9.4 Million
Q4 2019 Feb 11, 2020	BUY	$106.92 - $132.43 $7.24 Million - $8.96 Million	67,673 New	67,673 $8.89 Million

Others Institutions Holding LLY

# of Institutions

4,007

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $750B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Indie Asset Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Indie Asset Partners, LLC with notifications on news.

Account

Indie Asset Partners, LLC Eli Lilly & CO Transaction History